Search

Search Constraints

You searched for: Author/Creator Kelley, Michael J.

Search Results

1. Barriers to Prescribing Targeted Therapies for Patients With NSCLC With Highly Actionable Gene Variants in the Veterans Affairs National Precision Oncology Program. Issue 7 (July 2021)

2. Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration‐resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance). Issue 7 (21st November 2014)

6. EGFR mutation testing and TKI treatment patterns among veterans with stage III and IV non-small cell lung cancer. (2021)